Diffusion Pharmaceuticals
Diffusion Pharmaceuticals is a biotechnology firm that researches oxygen therapeutics for the treatment of cancer and orphan diseases.
Business Model:
Revenue: $7.3M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Diffusion Pharmaceuticals Information
Geographic Data
Address: 1317 Carlton Avenue
City: Charlottesville
State: VA
Zip: 22902
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$30M
Raised Total:$119M
Social
Metrics
4,760,842Website Global Rank
1,856Website Monthly Traffic
Twitter Followers
Description
Diffusion Pharmaceuticals is a biotechnology firm that researches oxygen therapeutics for the treatment of cancer and orphan diseases.
Contact Phone:
+14342200718
Contact Email:
Diffusion Pharmaceuticals went public on 1/8/2016 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/8/2016
Ticker Symbol:
DFFN
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2013 | Convertible Note | $5M | 9/2012 | Venture Round | $5M | 5/2019 | Private Placement | $6.3M | 11/2010 | Grant | $244.5k | 5/2020 | Post-IPO Equity | $12M | 12/2019 | Unattributed | $783.3k | 12/2019 | Post-IPO Equity | $3.5M | 4/2011 | Debt Financing | 1 | $2.2M |
Jaffray Woodriff Jaffray Woodriff |
4/2017 | Post-IPO Equity | $25M | 8/2014 | Convertible Note | 1 | $3.5M |
Jaffray Woodriff Jaffray Woodriff |
2/2004 | Grant | 1 | $1.2M |
Office of Naval Research Office of Naval Research |
8/2009 | Venture Round | $1.8M | 10/2004 | Grant | 1 | $10k |
Third Security Third Security |
10/2007 | Venture Round | $4.5M | 2/2007 | Grant | 1 | $500k |
Office of Naval Research Office of Naval Research |
7/2004 | Venture Round | $2.1M | 12/2009 | Debt Financing | 1 | $3.9M |
Jaffray Woodriff Jaffray Woodriff |
9/2004 | Grant | $1M | 5/2019 | Unattributed | $164.1k | 5/2019 | Post-IPO Equity | $6.5M | 3/2017 | Equity | $15.8M | 2/2021 | Post-IPO Equity | $30M | 1/2010 | Private Equity Round | $5.9M | 2/2009 | Private Equity Round | $2.9M | 12/2005 | Private Equity Round | $1.4M | 10/2006 | Private Equity Round | 1 | $1.5M |
U.S. Food and Drug Administration U.S. Food and Drug Administration |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 12/2015 | Stratus Media Group |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
